146 related articles for article (PubMed ID: 19319689)
1. AAPS-FIP summary workshop report: Pharmacogenetics in individualized medicine: methods, regulatory, and clinical applications.
Moridani M; Maitland-van der Zee AH; Sasaki H; McKinnon R; Fleckenstein L; Shah VP
AAPS J; 2009 Jun; 11(2):214-6. PubMed ID: 19319689
[TBL] [Abstract][Full Text] [Related]
2. Next-generation medicines: past regulatory experience and considerations for the future.
Pacanowski MA; Leptak C; Zineh I
Clin Pharmacol Ther; 2014 Mar; 95(3):247-9. PubMed ID: 24548989
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics and the concept of individualized medicine.
Shastry BS
Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics and pharmacogenomics in drug development and regulatory decision making: report of the first FDA-PWG-PhRMA-DruSafe Workshop.
Lesko LJ; Salerno RA; Spear BB; Anderson DC; Anderson T; Brazell C; Collins J; Dorner A; Essayan D; Gomez-Mancilla B; Hackett J; Huang SM; Ide S; Killinger J; Leighton J; Mansfield E; Meyer R; Ryan SG; Schmith V; Shaw P; Sistare F; Watson M; Worobec A
J Clin Pharmacol; 2003 Apr; 43(4):342-58. PubMed ID: 12723455
[TBL] [Abstract][Full Text] [Related]
5. 4th US FDA-Drug Information Association pharmacogenomics workshop, held 10-12 December, 2007.
Frueh FW; Salerno RA; Lesko LJ; Hockett RD
Pharmacogenomics; 2009 Jan; 10(1):111-5. PubMed ID: 19102720
[TBL] [Abstract][Full Text] [Related]
6. Enabling pharmacogenomic clinical trials through sampling.
Warner A; Nelsen A; Bhathena A; Fitzgerald K; Gilardi S; Kelso E; Knoppers B; McLeod HL; Nelson R; Uyama Y; Weisman J; Rudman A
Pharmacogenomics; 2010 Dec; 11(12):1649-54. PubMed ID: 21142907
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics-based therapeutic recommendations--ready for clinical practice?
Kirchheiner J; Fuhr U; Brockmöller J
Nat Rev Drug Discov; 2005 Aug; 4(8):639-47. PubMed ID: 16056390
[TBL] [Abstract][Full Text] [Related]
8. Drug-diagnostic codevelopment strategies: FDA and industry dialog at the 4th FDA/DIA/PhRMA/PWG/BIO Pharmacogenomics Workshop.
Hinman L; Spear B; Tsuchihashi Z; Kelly J; Bross P; Goodsaid F; Kalush F
Pharmacogenomics; 2009 Jan; 10(1):127-36. PubMed ID: 19102722
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics: from discovery to patient care.
Shin J; Kayser SR; Langaee TY
Am J Health Syst Pharm; 2009 Apr; 66(7):625-37. PubMed ID: 19299369
[TBL] [Abstract][Full Text] [Related]
10. From personalized medicine to personalized justice: the promises of translational pharmacogenomics in the justice system.
Wong SH; Happy C; Blinka D; Gock S; Jentzen JM; Donald Hon J; Coleman H; Jortani SA; Lucire Y; Morris-Kukoski CL; Neuman MG; Orsulak PJ; Sander T; Wagner MA; Wynn JR; Wu AH; Yeo KT
Pharmacogenomics; 2010 Jun; 11(6):731-7. PubMed ID: 20504247
[No Abstract] [Full Text] [Related]
11. [Clinical pharmacogenetics and future prospects in drug therapy].
Ariyoshi N
Nihon Yakurigaku Zasshi; 2002 Sep; 120(3):181-6. PubMed ID: 12271513
[TBL] [Abstract][Full Text] [Related]
12. Implications of pharmacogenomics for drug development and clinical practice.
Ginsburg GS; Konstance RP; Allsbrook JS; Schulman KA
Arch Intern Med; 2005 Nov; 165(20):2331-6. PubMed ID: 16287761
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacogenetics. Tailored therapy in medicine -- opportunities and challenges].
Scharplatz M; Puhan M; Steurer J; Bachmann LM
Praxis (Bern 1994); 2004 Mar; 93(10):359-65. PubMed ID: 15052854
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacogenetics--implications for health management and health care economics].
Weihrauch TR
Med Klin (Munich); 2002 Jul; 97(7):420-8. PubMed ID: 12168482
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics, pharmacogenomics, and individualized medicine.
Ma Q; Lu AY
Pharmacol Rev; 2011 Jun; 63(2):437-59. PubMed ID: 21436344
[TBL] [Abstract][Full Text] [Related]
16. A SNPshot: pharmacogenetics and the future of drug therapy.
Pfost DR; Boyce-Jacino MT; Grant DM
Trends Biotechnol; 2000 Aug; 18(8):334-8. PubMed ID: 10899814
[TBL] [Abstract][Full Text] [Related]
17. AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives.
Chaurasia CS; Müller M; Bashaw ED; Benfeldt E; Bolinder J; Bullock R; Bungay PM; DeLange EC; Derendorf H; Elmquist WF; Hammarlund-Udenaes M; Joukhadar C; Kellogg DL; Lunte CE; Nordstrom CH; Rollema H; Sawchuk RJ; Cheung BW; Shah VP; Stahle L; Ungerstedt U; Welty DF; Yeo H
Pharm Res; 2007 May; 24(5):1014-25. PubMed ID: 17458685
[TBL] [Abstract][Full Text] [Related]
18. Transforming the FDA in the age of personalized medicine-interview with Ray Woosley.
Musgrave E
Clin Transl Sci; 2008 May; 1(1):5. PubMed ID: 20443811
[No Abstract] [Full Text] [Related]
19. Pharmacogenetics: improving drug and dose selection.
Bhathena A; Spear BB
Curr Opin Pharmacol; 2008 Oct; 8(5):639-46. PubMed ID: 18762278
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics and the future of medical practice.
Lindpaintner K
Clin Lab; 2002; 48(5-6):335-45. PubMed ID: 12071585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
